MediWound forecasts a Q2 2026 EPS loss of $0.77 and revenue of $2.59M, reflecting sharp year-over-year declines.
MediWound (MDWD) will report Q2 2026 earnings on August 13 before the market opens. Analysts expect a loss of $0.77 per share, an improvement of 37.4% year-over-year, alongside revenue of $2.59M, down 54.6% from the same period last year.
The company has faced volatility in earnings over the past two years, with revenue declines outpacing improvements in EPS. Consensus estimates reflect ongoing challenges in revenue growth despite narrowing losses.
No immediate market reaction details were provided ahead of the release.